Novel Insight into Inhibitor Binding of Highly Symmetric HIV‐1 Protease
- 3 April 2008
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 9 (6) , 874-878
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- First Insight into the Symmetry and Flexibility of Membrane Efflux Pump P-Glycoprotein by Novel Bifunctional ModulatorsChemBioChem, 2005
- Dimeric 4-Aryl-1,4-Dihydropyridines: Development of a Third Class of Nonpeptidic HIV-1 Protease InhibitorsMini-Reviews in Medicinal Chemistry, 2002
- Strategies in the design of antiviral drugsNature Reviews Drug Discovery, 2002
- De novo design, discovery and development of cyclic urea HIV protease inhibitorsDrugs of the Future, 1998
- A Novel, Picomolar Inhibitor of Human Immunodeficiency Virus Type 1 ProteaseJournal of Medicinal Chemistry, 1996
- A symmetric inhibitor binds HIV-1 protease asymmetricallyBiochemistry, 1993
- A simple, continuous fluorometric assay for HIV proteaseInternational Journal of Peptide and Protein Research, 1990
- Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1Nature, 1989
- HTLV-III gag Protein Is Processed in Yeast Cells by the Virus pol -ProteaseScience, 1986
- Efficient removal of protecting groups by a 'push-pull' mechanism. II. Deprotection of O-benzyltyrosine with a thioanisole-trifluoroacetic acid system without O-to-C rearrangements.Chemical and Pharmaceutical Bulletin, 1980